LRRK2 inhibitor, MLi-2, Purity ≥98%

Cat. No.: X24-09-YM704

LRRK2 inhibitor, MLi-2, Purity ≥98%

Synonym: 1627091-47-7; MLi 2; MLi2; (2R,6S)-2,6-Dimethyl-4-[6-[5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl]pyrimidin-4-yl]morpholine; LRRK2 inhibitor

  • CAS Number: 1627091-47-7
  • Compound CID: 78319901
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
MLi-2, soluble in DMSO, water and ethanol, is an effective autophagy signaling inhibitor, that has the ability to prevent the pathway of autophagy signaling by inhibiting LRRK2. The molecular weight of the compound is 379.46, and its molecular formula is C21H25N5O2.
Molecular Weight
379.46
Molecular Formula
C21H25N5O2
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO: 72 mg/mL (189.74 mM); Water: 72 mg/mL (189.74 mM); Ethanol: 8 mg/mL (21.08 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
MLi-2 can be studied extensively for its potential therapeutic applications in the treatment of Parkinson’s disease and is also evaluated for its effects on inflammation and cellular stress responses.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0